Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ikigai Ventures is an early-stage venture capital firm and special purpose acquisition company, listed on the Main Market of the London Stock Exchange. It focuses on acquiring or investing in high-growth, purpose-driven companies with strong ESG strategies across multiple sectors, including healthcare, but also finance, agriculture, mining, artificial intelligence, gaming, mobility, e-sports, blockchain and frontier technologies. The company does not itself develop drugs or medical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ikigai Ventures.